{"ticker": {"uuid": "de4a94e6-2fef-4859-83a1-4f937f3f2e93", "symbol": "LKFT", "name": "Lakefront Biotherapeutics NV", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPT3lNZWpzWlNpTjVoWDB2WXR5cURWR1dFZnlsZnRNZ2ZFN1JfZXFpMm9oZ0Rqem1zbDRRa2ZZdGpHYWZWQlZrNE10NmY3RWxGSFo5amctbF9XaVRxejlibUlNelFtSkFTd1VELXd5MHVYWHN1OWNhcndlNHo3V2x5aXlOZmFCeWh4Z2pqQ3JQaVBaeXRnSVNPNTZrVVZJYUxwaEcwM01yVzktTHo2RzRLcG5maUhLVWYyOEltRE9UNHZNX3p0T0hlS3JOTWRLd2J5TGtmQl9HV0VmY3Y5anBDNkxXQXdoNGlabUZ0d3J6V2pNRmZ4am9STNIB_gFBVV95cUxNbVpxanlkeElGT3ZxZ3pTT21ZUHRBb204VVVmcU04MDZpckpFSWk3anFmWlJzbUx3S3lPN1FaN096QlMyUnhwV1piUjkwWFRIUks2T2s2enRWMFJ6bjZoLTU2dHB3eFVTcmtFdUZWYTN5UVhpTWlLb1dCZ1NIbW1teW1mYnMwek0zc3V1MlE1d2xZMk9Xbk12QVB2Q3BJRURVOGJrLUg2VWdKZzJqemx6cjljTk5CdDdqbFJuNDhLRzh6ZnpjYWd6OGR1bVYzWThaa2FFN0pjWFZKWDdqdVlaeElEa19XUi1xTHZ3b29xb3dhaWc4YkxnRENQUTJmZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T04:18:54+00:00", "published_display": "14 Jul 2026 04:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Lakefront Biotherapeutics NV Current Report (Foreign Issuer) | LKFT SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQb3BVOUhjb3FCWjFhYXYzWTYwMzNzUEQyckFwdzFJYjJsQzlxQTdUUlNHaWVxakdMcW41RWFzeEMxWHlKdWdLSmNjdFVrNnMybmpSNU5ZRjdrYmRocW9lUmZaMk92c0xhNUdKMjRkMUxqVUJrRTlJUGp4aHNma1JQbnBxZlRtcUgtcHlRd3NYbjFTOXp0dDlzaU1GbXVKMmszMndHWHVTZ005WTNYU1NoZ3UxVzRCcVN6MkZpQ2ZCTllxQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:33:06+00:00", "published_display": "13 Jul 2026 20:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQVZCRG5DQ3NBaDVueThyUFppX0FmbGZ4UndFNmJMdDZyZkxsQ0MxZjBvZVBlVlVvOVM3TW9zVTlNazdQV0VOLUpLZTh2X09QUXlNOVZvZm9mTE05Ukg4UGYxeFpWV3cweHBBd1JfZWI0NVUyRkliNFd6UFpxY2dnbVFtS2NudlVGOTdNMFgwNk9TOHdUMXVGekRRNXY3LVZoUWFXY0JtTG5SUFVZc2pOaUt1MzUzZUR2d3pVM25DNzR6VzBjamZKMGw0UUNIc1NzbEVTTFhoVFhnekxuVzZuVFpXQ25xcy1i?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T20:01:04+00:00", "published_display": "13 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics (LKFT) Coverage Resumed by Morgan Stan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcUF5TmtvYXBsN0hZR3ZZRTREQ09NR21UZVRMRWZxVGE5RHczZ0VQQVdrV01XcHBVRk5JX3ZhTXplVkxVOXZIR1ROdmFKcHhYbnJwbUNSYlpsajVVSWU3QUdobzNDMWVibDZaY2huTG81ZXBUVXhqYVNwUjB5Z3pUdkNqekpXU2FkTjI1emRkLXNUa1NEOU1KM19TalpnSWVhSXNOM2x0OGg2TEtIZUVlZURGRDYtRWZyUlpR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T17:33:01+00:00", "published_display": "10 Jul 2026 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront draws Equal Weight rating at Morgan Stanley (LKFT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPTThhT01fZC12Mmw2cDE4SmlIMFRBbF9ibTc3Um1uNlVLTFhUZWp4SjdSQUNKQ29NWVJzS1poSHJsWEFkNHV5MEQ2OUpFbWNMYi1hMDk2NGlEdlRoMTRCSlRIbXkzSDZBNkY1dmlSU3B4eEtIcmFhalNjNW9YUlVELWdTTEtNdVpPUllNb0pHR212Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T16:41:27+00:00", "published_display": "10 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Initiation of \u20ac50 Million Stock Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUktwRmpMQ2VoWFM2RlFNWjNTZEI0SXlFMWtFT0RBNDkxTnBKVW1Lc3N0Vk9la2FYV3pxOVBYTGgtM3Z2aGY2SjBVQ2wyVDhQSEt3YmFEWkpLYlUyNUtHLXAwSzN4cG9xWnlYclYtdm9mS3NDMDJGWEkyazAzSDBaazRDMndPeDBkaFk5eE52RGlvSnZqVU04LTJCdXFfN3kwYVpEM0p3dUNRZ3pWZ2t6a2tyY0p4Z1Rta0tuQ1cyR1otQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics NV: Target Price Consensus and Analysts Recommendations | LKFT | BE0003818359", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNdm8zTmpwYVpaWTNjUW9xSHhkMmdFRV9raDg1cy1jam55QlpUcnp0LUxwSUtkSDdtc2JPOERDMzJueUk5aWQ2bkE3UldHV1lRbjNOSTZvRkc2dWJrZWZFb3ZjblNBSGN4RFoxYzlPTkVsM2ZWT09QQm5rYUFpckh3SXJGaExXTjdJNU9LMA?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-28T15:18:54+00:00", "published_display": "28 May 2026 15:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Report: Lakefront Biotherapeutics NV Missed Revenue Estimates By 78%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9qdDdJT05vRTNrWVhnMmozbE5QajNMdGVFWTM5Y0wwNWVpWUt3VHRFSUxONmFRRE00X004eF95WEI5dmJmcXExc1V0RC14bExUUWZnV1pCNHpoQUJmcG1QN2F3NkczQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-10T05:12:57+00:00", "published_display": "10 May 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics NV 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:LKFT) 2026-05-09", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQWUItTUZiNGFRcm5RSm13V3F3aVJzMUd4MlJQNFJ3Y2hPYjNLaFpDVEVtbnJWOE03NUNhZ04wQUczTnlOTzRkQVdtRFE5REJycHZMeVQ0a21sdmpvMnVzbkRoaXAxOWR2LU1GdVFVWjVGYngweDFGMUpzVmFrN0JuSFc4ZXNGN1RITzU5QlNpTjZhNi1FUlRpazFUUEl0T2FrR0hsQkJFa2R5S0lpOEpVNDd3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPT3lNZWpzWlNpTjVoWDB2WXR5cURWR1dFZnlsZnRNZ2ZFN1JfZXFpMm9oZ0Rqem1zbDRRa2ZZdGpHYWZWQlZrNE10NmY3RWxGSFo5amctbF9XaVRxejlibUlNelFtSkFTd1VELXd5MHVYWHN1OWNhcndlNHo3V2x5aXlOZmFCeWh4Z2pqQ3JQaVBaeXRnSVNPNTZrVVZJYUxwaEcwM01yVzktTHo2RzRLcG5maUhLVWYyOEltRE9UNHZNX3p0T0hlS3JOTWRLd2J5TGtmQl9HV0VmY3Y5anBDNkxXQXdoNGlabUZ0d3J6V2pNRmZ4am9STNIB_gFBVV95cUxNbVpxanlkeElGT3ZxZ3pTT21ZUHRBb204VVVmcU04MDZpckpFSWk3anFmWlJzbUx3S3lPN1FaN096QlMyUnhwV1piUjkwWFRIUks2T2s2enRWMFJ6bjZoLTU2dHB3eFVTcmtFdUZWYTN5UVhpTWlLb1dCZ1NIbW1teW1mYnMwek0zc3V1MlE1d2xZMk9Xbk12QVB2Q3BJRURVOGJrLUg2VWdKZzJqemx6cjljTk5CdDdqbFJuNDhLRzh6ZnpjYWd6OGR1bVYzWThaa2FFN0pjWFZKWDdqdVlaeElEa19XUi1xTHZ3b29xb3dhaWc4YkxnRENQUTJmZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T04:18:54+00:00", "published_display": "14 Jul 2026 04:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Lakefront Biotherapeutics NV Current Report (Foreign Issuer) | LKFT SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQb3BVOUhjb3FCWjFhYXYzWTYwMzNzUEQyckFwdzFJYjJsQzlxQTdUUlNHaWVxakdMcW41RWFzeEMxWHlKdWdLSmNjdFVrNnMybmpSNU5ZRjdrYmRocW9lUmZaMk92c0xhNUdKMjRkMUxqVUJrRTlJUGp4aHNma1JQbnBxZlRtcUgtcHlRd3NYbjFTOXp0dDlzaU1GbXVKMmszMndHWHVTZ005WTNYU1NoZ3UxVzRCcVN6MkZpQ2ZCTllxQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:33:06+00:00", "published_display": "13 Jul 2026 20:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQVZCRG5DQ3NBaDVueThyUFppX0FmbGZ4UndFNmJMdDZyZkxsQ0MxZjBvZVBlVlVvOVM3TW9zVTlNazdQV0VOLUpLZTh2X09QUXlNOVZvZm9mTE05Ukg4UGYxeFpWV3cweHBBd1JfZWI0NVUyRkliNFd6UFpxY2dnbVFtS2NudlVGOTdNMFgwNk9TOHdUMXVGekRRNXY3LVZoUWFXY0JtTG5SUFVZc2pOaUt1MzUzZUR2d3pVM25DNzR6VzBjamZKMGw0UUNIc1NzbEVTTFhoVFhnekxuVzZuVFpXQ25xcy1i?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T20:01:04+00:00", "published_display": "13 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics (LKFT) Coverage Resumed by Morgan Stan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcUF5TmtvYXBsN0hZR3ZZRTREQ09NR21UZVRMRWZxVGE5RHczZ0VQQVdrV01XcHBVRk5JX3ZhTXplVkxVOXZIR1ROdmFKcHhYbnJwbUNSYlpsajVVSWU3QUdobzNDMWVibDZaY2huTG81ZXBUVXhqYVNwUjB5Z3pUdkNqekpXU2FkTjI1emRkLXNUa1NEOU1KM19TalpnSWVhSXNOM2x0OGg2TEtIZUVlZURGRDYtRWZyUlpR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T17:33:01+00:00", "published_display": "10 Jul 2026 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront draws Equal Weight rating at Morgan Stanley (LKFT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPTThhT01fZC12Mmw2cDE4SmlIMFRBbF9ibTc3Um1uNlVLTFhUZWp4SjdSQUNKQ29NWVJzS1poSHJsWEFkNHV5MEQ2OUpFbWNMYi1hMDk2NGlEdlRoMTRCSlRIbXkzSDZBNkY1dmlSU3B4eEtIcmFhalNjNW9YUlVELWdTTEtNdVpPUllNb0pHR212Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T16:41:27+00:00", "published_display": "10 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Initiation of \u20ac50 Million Stock Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQUktwRmpMQ2VoWFM2RlFNWjNTZEI0SXlFMWtFT0RBNDkxTnBKVW1Lc3N0Vk9la2FYV3pxOVBYTGgtM3Z2aGY2SjBVQ2wyVDhQSEt3YmFEWkpLYlUyNUtHLXAwSzN4cG9xWnlYclYtdm9mS3NDMDJGWEkyazAzSDBaazRDMndPeDBkaFk5eE52RGlvSnZqVU04LTJCdXFfN3kwYVpEM0p3dUNRZ3pWZ2t6a2tyY0p4Z1Rta0tuQ1cyR1otQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics NV: Target Price Consensus and Analysts Recommendations | LKFT | BE0003818359", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNdm8zTmpwYVpaWTNjUW9xSHhkMmdFRV9raDg1cy1jam55QlpUcnp0LUxwSUtkSDdtc2JPOERDMzJueUk5aWQ2bkE3UldHV1lRbjNOSTZvRkc2dWJrZWZFb3ZjblNBSGN4RFoxYzlPTkVsM2ZWT09QQm5rYUFpckh3SXJGaExXTjdJNU9LMA?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-28T15:18:54+00:00", "published_display": "28 May 2026 15:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Report: Lakefront Biotherapeutics NV Missed Revenue Estimates By 78%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9qdDdJT05vRTNrWVhnMmozbE5QajNMdGVFWTM5Y0wwNWVpWUt3VHRFSUxONmFRRE00X004eF95WEI5dmJmcXExc1V0RC14bExUUWZnV1pCNHpoQUJmcG1QN2F3NkczQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-10T05:12:57+00:00", "published_display": "10 May 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics NV 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:LKFT) 2026-05-09", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQWUItTUZiNGFRcm5RSm13V3F3aVJzMUd4MlJQNFJ3Y2hPYjNLaFpDVEVtbnJWOE03NUNhZ04wQUczTnlOTzRkQVdtRFE5REJycHZMeVQ0a21sdmpvMnVzbkRoaXAxOWR2LU1GdVFVWjVGYngweDFGMUpzVmFrN0JuSFc4ZXNGN1RITzU5QlNpTjZhNi1FUlRpazFUUEl0T2FrR0hsQkJFa2R5S0lpOEpVNDd3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 10, "sentiment_summary": {"positive": 0, "negative": 2, "neutral": 8, "score": 47, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "analyst", "primary_label": "Analyst action", "confidence": 71, "events": [{"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 2.0, "count": 3}, {"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 26.44, "latest_week": "2026-07-10", "one_week_move": -1.7, "four_week_move": 5.4, "twelve_week_move": 6.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.307176, "market_dynamics_buy_signal": false, "relative_strength": -20.987144, "fair_value_gap": -5.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.728, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.7% over one week, +5.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Analyst action", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "Seeking Alpha", "count": 2}, {"label": "Stock Titan", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Analyst action", "count": 3}, {"label": "Market update", "count": 3}, {"label": "Earnings", "count": 3}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "47/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Analyst action", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.7% over one week, +5.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today"}], "updated_at": "2026-07-18T02:33:05.792333+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}